サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1424966

皮膚代替品・代用品の世界市場：市場規模・シェア分析 (製品別・クラス別・用途別・エンドユーザー別)、産業需要の予測 (2030年まで)

Skin Replacements and Substitutes Market Size and Share Analysis by Product, Class, Application, End User - Global Industry Demand Forecast to 2030
出版日: | 発行: Prescient & Strategic Intelligence | ページ情報: 英文 350 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
皮膚代替品・代用品の世界市場：市場規模・シェア分析 (製品別・クラス別・用途別・エンドユーザー別)、産業需要の予測 (2030年まで)
出版日: 2024年02月01日
発行: Prescient & Strategic Intelligence
ページ情報: 英文 350 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の皮膚代替品・代用品の市場規模は、2024年から2030年にかけて7.0%のCAGRを記録し、2030年までに18億6,920万米ドルに達すると予測されています。この背景には、外見の美しさにお金をかける市民の増加、火傷の発生率の上昇、交通事故率の増加、平均寿命の急上昇、皮膚疾患や慢性疾患の有病率の上昇があります。WHOによると、インドでは毎年100万人近くが重症・中等度の火傷を負っています。インドにおける障害調整生存年数の高さは、火傷をはじめとする多くの原因によるものです。

外見の美しさへの関心増大：

慢性疾患やその他の理由で皮膚に損傷を受けた人々が、外見を美しくするための治療法を求めるようになっています。さらに、医療分野の技術革新により、無細胞皮膚代替物など、皮膚の代わりとして使用できるさまざまな製品が利用できるようになりました。これらの製品では、ナイロンメッシュが真皮として機能し、シリコン膜が表皮として機能します。その後、ブタのコラーゲンに移植され、化学結合によって創傷底面に接着されます。

深い熱傷は皮膚の両層 (真皮と表皮) を破壊し、微生物にさらすため、感染症やさらなる合併症を引き起こす可能性があります。そのため、迅速な医療指導や手術が勧められます。滅菌後の人工皮膚は、破壊された組織を再生させるためのサイトカインや成長因子の放出を促進する能力があります。移植片の幅や開口部、連通気孔は、新しい皮膚の再生にとって理想的でなければなりません。

創傷治療クリニック・病院の市場での優位性の継続：

創傷治療クリニックや病院は、洗練された設備、専門家、必要な薬剤、複雑な熱傷症例に必要な技術を持っているため、最大のエンドユーザーです。皮膚疾患を患う人の増加に伴い、こうした医療センターへの訪問者数は増加しています。さらに、深刻な創傷は手術後に引き起こされるため、このような皮膚置換術はしばしば術後ケア全体のレジメンの一部となっています。

アジア太平洋における成長機会：

北米は、医療分野の進歩やスキンケア需要の高さから市場を独占しています。さらに、大手企業は病院や美容センター、創傷治療クリニックと連携して、皮膚代替品・代用品の販売と開発を進め、FDAの承認取得を目指しています。例えば、2021年6月、Mallinckrodt Pharmaceuticals社はStrataGraftと呼ばれる新規皮膚製品のFDA承認を取得しました。この製品は、熱による火傷の後、皮膚深層と真皮要素の一部が無傷のまま残っている場合、自家移植の必要性を減らすことができます。

アジア太平洋 (APAC) は、美容整形に対する需要の増加や、糖尿病性足潰瘍 (DFU) などの皮膚疾患の有病率の高さにより、最も急成長している市場です。糖尿病人口の15～25%が、ある時点でDFUを発症します。WHOによると、中国の糖尿病人口は2016年の1億1,000万人から2040年には1億5,000万人に達すると予想されています。さらに、インドでは2019年から2021年にかけて3,100万人が新たに糖尿病と診断されました。

当レポートでは、世界の皮膚代替品・代用品の市場について分析し、市場の基本構造・最新情勢や主な促進・抑制要因、世界全体および地域別・主要国の市場規模の動向見通し (金額ベース、2017～2030年)、製品別・クラス別・用途別・エンドユーザー別の詳細動向、現在の市場競争の状況、主要企業のプロファイルなどを調査しております。

目次

第1章 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場指標

第5章 業界の展望

  • 市場力学
    • 動向
    • 促進要因
    • 抑制要因/課題
    • 促進要因/抑制要因の影響分析
  • 新型コロナウイルス感染症 (COVID-19) の影響
  • ポーターのファイブフォース分析

第6章 世界市場

  • 概要
  • 市場収益：製品別 (2017～2030年)
  • 市場収益：クラス別 (2017～2030年)
    • クラスIの市場収益：種類別 (2017～2030年)
    • クラスIIの市場収益：種類別 (2017～2030年)
    • クラスIIIの市場収益：種類別 (2017～2030年)
  • 市場収益：用途別 (2017～2030年)
  • 市場収益：エンドユーザー別 (2017～2030年)
  • 市場収益：地域別 (2017～2030年)

第7章 北米市場

  • 概要
  • 市場収益：製品別 (2017～2030年)
  • 市場収益：クラス別 (2017～2030年)
    • クラスIの市場収益：種類別 (2017～2030年)
    • クラスIIの市場収益：種類別 (2017～2030年)
    • クラスIIIの市場収益：種類別 (2017～2030年)
  • 市場収益：用途別 (2017～2030年)
  • 市場収益：エンドユーザー別 (2017～2030年)
  • 市場収益：国別 (2017～2030年)

第8章 欧州市場

第9章 アジア太平洋市場

第10章 ラテンアメリカ市場

第11章 中東・アフリカ (MEA) 市場

第12章 米国市場

  • 概要
  • 市場収益：製品別 (2017～2030年)
  • 市場収益：クラス別 (2017～2030年)
    • クラスIの市場収益：種類別 (2017～2030年)
    • クラスIIの市場収益：種類別 (2017～2030年)
    • クラスIIIの市場収益：種類別 (2017～2030年)
  • 市場収益：用途別 (2017～2030年)
  • 市場収益：エンドユーザー別 (2017～2030年)

第13章 カナダ市場

第14章 ドイツ市場

第15章 フランス市場

第16章 英国市場

第17章 イタリア市場

第18章 スペイン市場

第19章 日本市場

第20章 中国市場

第21章 インド市場

第22章 オーストラリア市場

第23章 韓国市場

第24章 ブラジル市場

第25章 メキシコ市場

第26章 サウジアラビア市場

第27章 南アフリカ市場

第28章 アラブ首長国連邦 (UAE) 市場

第29章 競合情勢

  • 市場参入企業とその提供製品/サービスの一覧
  • 主要企業の競合ベンチマーク
  • 主要企業の製品ベンチマーク
  • 最近の戦略展開状況

第30章 企業プロファイル

  • Acelity L.P. Inc.
  • MiMedx Group Inc.
  • Organogenesis Inc.
  • Vericel Corporation
  • FUJIFILM Cellular Dynamics Inc.
  • Smith & Nephew plc
  • Integra LifeSciences Holdings Corporation
  • AlloSource
  • MatTek Corporation

第31章 付録

目次
Product Code: 11704

The global skin replacements and substitutes market size is set to be USD 1,869.2 million by 2030, witnessing 7.0% CAGR between 2024 and 2030. This will be due to the increasing number of citizens spending on appearance enhancement, rising incidence of burns, growing rate of road accidents, surging life expectancy, and escalating prevalence of skin and chronic disease. As per the WHO, nearly 1 million people in India get severe and moderate burns each year. The high disability-adjusted life-years in India are due to burns and many other causes.

Increasing Focus on Enhance Appearance of Skin

People with skin damage due to chronic diseases and other reasons are increasingly seeking remedies to enhance their appearance. Further, due to the innovations in the healthcare sector, various products are available for use as skin replacement, such as acellular substitutes; these products are cost-effective and efficient. In these products, a nylon mesh works as the dermis, and a silicon membrane works as the epidermis. It is then implanted into porcine collagen and connected by chemical bonds for attachment to the wound base.

Deep burns can destroy both layers of the skin (dermis and epidermis), exposing them to microorganisms, which can cause infections and further complications. Therefore, quick medical guidance or surgery is advised. Artificial skin, after sterilization, has the capacity to enhance the release of cytokines and growth factors for regenerating the destroyed tissue. The width, orifice, and interconnecting pores of the graft should be ideal for the regeneration of new skin.

Continued Dominance of Wound Care Clinics and Hospitals on Market

Wound care clinics and hospitals are the largest end users as they have sophisticated facilities, expert professionals, necessary medication, and the technology required for complicated burn cases. With an increasing number of people suffering from dermatological diseases, the footfall at these healthcare centers is rising. Moreover, severe wounds are caused after surgery; hence, such skin replacement procedures are often part of the overall post-operative care regimen.

Growing Opportunities in APAC

North America is dominating the market due to the advancements in the healthcare sector and a high demand for skincare. Moreover, the key market players are collaborating with hospitals, cosmetic centers, and wound care clinics to sell and advance their skin replacement and substitute products and pursuing the approval of the FDA for them. For instance, in June 2021 Mallinckrodt Pharmaceuticals received the FDA approval for a novel skin product, called StrataGraft. It can reduce the requirement for autografts if some part of the deeper skin layers and dermal elements remains intact after a thermal burn injury.

APAC is the fastest-growing market due to the increasing demand for cosmetic procedures and the high prevalence of diabetic foot ulcers and other skin issues. Between 15 and 25% of the population with diabetes mellitus would develop a DFU at some point. As per the WHO, diabetic population in China is expected to reach 150 million by 2040 from 110 million in 2016. Moreover, India registered 31 million new diabetes diagnoses in 2019-2021.

Some of the key players in the skin and replacements and substitutes market are Acelity L.P. Inc., MiMedx Group Inc., Organogenesis Inc., Vericel Corporation, FUJIFILM Cellular Dynamics Inc., Smith & Nephew plc, Integra LifeSciences Holdings Corporation, AlloSource, and MatTek Corporation.

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by product
    • 1.4.2. Market size breakdown, by class
    • 1.4.3. Market size breakdown, by application
    • 1.4.4. Market size breakdown, by end user
    • 1.4.5. Market size breakdown, by region
    • 1.4.6. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. Global Market

  • 6.1. Overview
  • 6.2. Market Revenue, by Product (2017-2030)
  • 6.3. Market Revenue, by Class (2017-2030)
    • 6.3.1. Class I market revenue, by type (2017-2030)
    • 6.3.2. Class II market revenue, by type (2017-2030)
    • 6.3.3. Class III market revenue, by type (2017-2030)
  • 6.4. Market Revenue, by Application (2017-2030)
  • 6.5. Market Revenue, by End User (2017-2030)
  • 6.6. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

  • 7.1. Overview
  • 7.2. Market Revenue, by Product (2017-2030)
  • 7.3. Market Revenue, by Class (2017-2030)
    • 7.3.1. Class I market revenue, by type (2017-2030)
    • 7.3.2. Class II market revenue, by type (2017-2030)
    • 7.3.3. Class III market revenue, by type (2017-2030)
  • 7.4. Market Revenue, by Application (2017-2030)
  • 7.5. Market Revenue, by End User (2017-2030)
  • 7.6. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

  • 8.1. Overview
  • 8.2. Market Revenue, by Product (2017-2030)
  • 8.3. Market Revenue, by Class (2017-2030)
    • 8.3.1. Class I market revenue, by type (2017-2030)
    • 8.3.2. Class II market revenue, by type (2017-2030)
    • 8.3.3. Class III market revenue, by type (2017-2030)
  • 8.4. Market Revenue, by Application (2017-2030)
  • 8.5. Market Revenue, by End User (2017-2030)
  • 8.6. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

  • 9.1. Overview
  • 9.2. Market Revenue, by Product (2017-2030)
  • 9.3. Market Revenue, by Class (2017-2030)
    • 9.3.1. Class I market revenue, by type (2017-2030)
    • 9.3.2. Class II market revenue, by type (2017-2030)
    • 9.3.3. Class III market revenue, by type (2017-2030)
  • 9.4. Market Revenue, by Application (2017-2030)
  • 9.5. Market Revenue, by End User (2017-2030)
  • 9.6. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

  • 10.1. Overview
  • 10.2. Market Revenue, by Product (2017-2030)
  • 10.3. Market Revenue, by Class (2017-2030)
    • 10.3.1. Class I market revenue, by type (2017-2030)
    • 10.3.2. Class II market revenue, by type (2017-2030)
    • 10.3.3. Class III market revenue, by type (2017-2030)
  • 10.4. Market Revenue, by Application (2017-2030)
  • 10.5. Market Revenue, by End User (2017-2030)
  • 10.6. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

  • 11.1. Overview
  • 11.2. Market Revenue, by Product (2017-2030)
  • 11.3. Market Revenue, by Class (2017-2030)
    • 11.3.1. Class I market revenue, by type (2017-2030)
    • 11.3.2. Class II market revenue, by type (2017-2030)
    • 11.3.3. Class III market revenue, by type (2017-2030)
  • 11.4. Market Revenue, by Application (2017-2030)
  • 11.5. Market Revenue, by End User (2017-2030)
  • 11.6. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

  • 12.1. Overview
  • 12.2. Market Revenue, by Product (2017-2030)
  • 12.3. Market Revenue, by Class (2017-2030)
    • 12.3.1. Class I market revenue, by type (2017-2030)
    • 12.3.2. Class II market revenue, by type (2017-2030)
    • 12.3.3. Class III market revenue, by type (2017-2030)
  • 12.4. Market Revenue, by Application (2017-2030)
  • 12.5. Market Revenue, by End User (2017-2030)

Chapter 13. Canada Market

  • 13.1. Overview
  • 13.2. Market Revenue, by Product (2017-2030)
  • 13.3. Market Revenue, by Class (2017-2030)
    • 13.3.1. Class I market revenue, by type (2017-2030)
    • 13.3.2. Class II market revenue, by type (2017-2030)
    • 13.3.3. Class III market revenue, by type (2017-2030)
  • 13.4. Market Revenue, by Application (2017-2030)
  • 13.5. Market Revenue, by End User (2017-2030)

Chapter 14. Germany Market

  • 14.1. Overview
  • 14.2. Market Revenue, by Product (2017-2030)
  • 14.3. Market Revenue, by Class (2017-2030)
    • 14.3.1. Class I market revenue, by type (2017-2030)
    • 14.3.2. Class II market revenue, by type (2017-2030)
    • 14.3.3. Class III market revenue, by type (2017-2030)
  • 14.4. Market Revenue, by Application (2017-2030)
  • 14.5. Market Revenue, by End User (2017-2030)

Chapter 15. France Market

  • 15.1. Overview
  • 15.2. Market Revenue, by Product (2017-2030)
  • 15.3. Market Revenue, by Class (2017-2030)
    • 15.3.1. Class I market revenue, by type (2017-2030)
    • 15.3.2. Class II market revenue, by type (2017-2030)
    • 15.3.3. Class III market revenue, by type (2017-2030)
  • 15.4. Market Revenue, by Application (2017-2030)
  • 15.5. Market Revenue, by End User (2017-2030)

Chapter 16. U.K. Market

  • 16.1. Overview
  • 16.2. Market Revenue, by Product (2017-2030)
  • 16.3. Market Revenue, by Class (2017-2030)
    • 16.3.1. Class I market revenue, by type (2017-2030)
    • 16.3.2. Class II market revenue, by type (2017-2030)
    • 16.3.3. Class III market revenue, by type (2017-2030)
  • 16.4. Market Revenue, by Application (2017-2030)
  • 16.5. Market Revenue, by End User (2017-2030)

Chapter 17. Italy Market

  • 17.1. Overview
  • 17.2. Market Revenue, by Product (2017-2030)
  • 17.3. Market Revenue, by Class (2017-2030)
    • 17.3.1. Class I market revenue, by type (2017-2030)
    • 17.3.2. Class II market revenue, by type (2017-2030)
    • 17.3.3. Class III market revenue, by type (2017-2030)
  • 17.4. Market Revenue, by Application (2017-2030)
  • 17.5. Market Revenue, by End User (2017-2030)

Chapter 18. Spain Market

  • 18.1. Overview
  • 18.2. Market Revenue, by Product (2017-2030)
  • 18.3. Market Revenue, by Class (2017-2030)
    • 18.3.1. Class I market revenue, by type (2017-2030)
    • 18.3.2. Class II market revenue, by type (2017-2030)
    • 18.3.3. Class III market revenue, by type (2017-2030)
  • 18.4. Market Revenue, by Application (2017-2030)
  • 18.5. Market Revenue, by End User (2017-2030)

Chapter 19. Japan Market

  • 19.1. Overview
  • 19.2. Market Revenue, by Product (2017-2030)
  • 19.3. Market Revenue, by Class (2017-2030)
    • 19.3.1. Class I market revenue, by type (2017-2030)
    • 19.3.2. Class II market revenue, by type (2017-2030)
    • 19.3.3. Class III market revenue, by type (2017-2030)
  • 19.4. Market Revenue, by Application (2017-2030)
  • 19.5. Market Revenue, by End User (2017-2030)

Chapter 20. China Market

  • 20.1. Overview
  • 20.2. Market Revenue, by Product (2017-2030)
  • 20.3. Market Revenue, by Class (2017-2030)
    • 20.3.1. Class I market revenue, by type (2017-2030)
    • 20.3.2. Class II market revenue, by type (2017-2030)
    • 20.3.3. Class III market revenue, by type (2017-2030)
  • 20.4. Market Revenue, by Application (2017-2030)
  • 20.5. Market Revenue, by End User (2017-2030)

Chapter 21. India Market

  • 21.1. Overview
  • 21.2. Market Revenue, by Product (2017-2030)
  • 21.3. Market Revenue, by Class (2017-2030)
    • 21.3.1. Class I market revenue, by type (2017-2030)
    • 21.3.2. Class II market revenue, by type (2017-2030)
    • 21.3.3. Class III market revenue, by type (2017-2030)
  • 21.4. Market Revenue, by Application (2017-2030)
  • 21.5. Market Revenue, by End User (2017-2030)

Chapter 22. Australia Market

  • 22.1. Overview
  • 22.2. Market Revenue, by Product (2017-2030)
  • 22.3. Market Revenue, by Class (2017-2030)
    • 22.3.1. Class I market revenue, by type (2017-2030)
    • 22.3.2. Class II market revenue, by type (2017-2030)
    • 22.3.3. Class III market revenue, by type (2017-2030)
  • 22.4. Market Revenue, by Application (2017-2030)
  • 22.5. Market Revenue, by End User (2017-2030)

Chapter 23. South Korea Market

  • 23.1. Overview
  • 23.2. Market Revenue, by Product (2017-2030)
  • 23.3. Market Revenue, by Class (2017-2030)
    • 23.3.1. Class I market revenue, by type (2017-2030)
    • 23.3.2. Class II market revenue, by type (2017-2030)
    • 23.3.3. Class III market revenue, by type (2017-2030)
  • 23.4. Market Revenue, by Application (2017-2030)
  • 23.5. Market Revenue, by End User (2017-2030)

Chapter 24. Brazil Market

  • 24.1. Overview
  • 24.2. Market Revenue, by Product (2017-2030)
  • 24.3. Market Revenue, by Class (2017-2030)
    • 24.3.1. Class I market revenue, by type (2017-2030)
    • 24.3.2. Class II market revenue, by type (2017-2030)
    • 24.3.3. Class III market revenue, by type (2017-2030)
  • 24.4. Market Revenue, by Application (2017-2030)
  • 24.5. Market Revenue, by End User (2017-2030)

Chapter 25. Mexico Market

  • 25.1. Overview
  • 25.2. Market Revenue, by Product (2017-2030)
  • 25.3. Market Revenue, by Class (2017-2030)
    • 25.3.1. Class I market revenue, by type (2017-2030)
    • 25.3.2. Class II market revenue, by type (2017-2030)
    • 25.3.3. Class III market revenue, by type (2017-2030)
  • 25.4. Market Revenue, by Application (2017-2030)
  • 25.5. Market Revenue, by End User (2017-2030)

Chapter 26. Saudi Arabia Market

  • 26.1. Overview
  • 26.2. Market Revenue, by Product (2017-2030)
  • 26.3. Market Revenue, by Class (2017-2030)
    • 26.3.1. Class I market revenue, by type (2017-2030)
    • 26.3.2. Class II market revenue, by type (2017-2030)
    • 26.3.3. Class III market revenue, by type (2017-2030)
  • 26.4. Market Revenue, by Application (2017-2030)
  • 26.5. Market Revenue, by End User (2017-2030)

Chapter 27. South Africa Market

  • 27.1. Overview
  • 27.2. Market Revenue, by Product (2017-2030)
  • 27.3. Market Revenue, by Class (2017-2030)
    • 27.3.1. Class I market revenue, by type (2017-2030)
    • 27.3.2. Class II market revenue, by type (2017-2030)
    • 27.3.3. Class III market revenue, by type (2017-2030)
  • 27.4. Market Revenue, by Application (2017-2030)
  • 27.5. Market Revenue, by End User (2017-2030)

Chapter 28. U.A.E. Market

  • 28.1. Overview
  • 28.2. Market Revenue, by Product (2017-2030)
  • 28.3. Market Revenue, by Class (2017-2030)
    • 28.3.1. Class I market revenue, by type (2017-2030)
    • 28.3.2. Class II market revenue, by type (2017-2030)
    • 28.3.3. Class III market revenue, by type (2017-2030)
  • 28.4. Market Revenue, by Application (2017-2030)
  • 28.5. Market Revenue, by End User (2017-2030)

Chapter 29. Competitive Landscape

  • 29.1. List of Market Players and their Offerings
  • 29.2. Competitive Benchmarking of Key Players
  • 29.3. Product Benchmarking of Key Players
  • 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

  • 30.1. Acelity L.P. Inc.
    • 30.1.1. Business overview
    • 30.1.2. Product and service offerings
    • 30.1.3. Key financial summary
  • 30.2. MiMedx Group Inc.
    • 30.2.1. Business overview
    • 30.2.2. Product and service offerings
    • 30.2.3. Key financial summary
  • 30.3. Organogenesis Inc.
    • 30.3.1. Business overview
    • 30.3.2. Product and service offerings
    • 30.3.3. Key financial summary
  • 30.4. Vericel Corporation
    • 30.4.1. Business overview
    • 30.4.2. Product and service offerings
    • 30.4.3. Key financial summary
  • 30.5. FUJIFILM Cellular Dynamics Inc.
    • 30.5.1. Business overview
    • 30.5.2. Product and service offerings
    • 30.5.3. Key financial summary
  • 30.6. Smith & Nephew plc
    • 30.6.1. Business overview
    • 30.6.2. Product and service offerings
    • 30.6.3. Key financial summary
  • 30.7. Integra LifeSciences Holdings Corporation
    • 30.7.1. Business overview
    • 30.7.2. Product and service offerings
    • 30.7.3. Key financial summary
  • 30.8. AlloSource
    • 30.8.1. Business overview
    • 30.8.2. Product and service offerings
    • 30.8.3. Key financial summary
  • 30.9. MatTek Corporation
    • 30.9.1. Business overview
    • 30.9.2. Product and service offerings
    • 30.9.3. Key financial summary

Chapter 31. Appendix

  • 31.1. Abbreviations
  • 31.2. Sources and References
  • 31.3. Related Reports